Inogen outlines path to 6% revenue growth in 2026 while launching $30M share repurchase program
Source: SeekingAlpha
2026-02-24 21:08:23 ET
More on Inogen
- Inogen, Inc. (INGN) Q4 2025 Earnings Call Transcript
- Inogen, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on Inogen
- Historical earnings data for Inogen
- Financial information for Inogen
Read the full article on Seeking Alpha
For further details see:
Inogen outlines path to 6% revenue growth in 2026 while launching $30M share repurchase program
Inogen Inc
NASDAQ: INGN
INGN Trading
-1.95% G/L:
$6.29 Last:
105,608 Volume:
$6.37 Open:
INGN Latest News
March 05, 2026 09:15:00 am
Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum
February 24, 2026 04:05:00 pm
Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook
INGN Stock Data
$157,325,453
26,876,997
0.49%
33
N/A
Medical Equipment & Supplies
Healthcare
US
Goleta
